Nevada adopts NAC 453.510 Schedule I additions: dipentylone and seven fentanyl-related substances (LCB File R107-25)

Nevada State Board of Pharmacy adopted an amendment to NAC 453.510 (Schedule I) adding dipentylone and seven fentanyl-related substances (para-chlorofentanyl; ortho-chlorofentanyl; meta-fluorofuranyl fentanyl; ortho-methylcyclopropyl fentanyl; beta-methylacetyl fentanyl; tetrahydrothiophenyl/tetrahydrothiofuranyl fentanyl; para-fluoro valeryl fentanyl). The adoption record states the purpose is to conform Nevada’s Schedule I list with the federal Controlled Substances Act pursuant to Nevada’s Uniform Controlled Substances Act authorities (e.g., NRS 453.211 and NRS 453.2182). Compliance impact: Nevada registrants handling controlled substances (manufacturers, distributors, pharmacies, researchers, etc.) should update controlled-substance inventories, handling controls, and related policies to reflect these Schedule I additions.